Efficacy and safety of Moricizine in the maintenance of sinus rhythm in patients with recurrent atrial fibrillation

American Journal of Cardiology

Volumn 87, Issue 2, 2001, Pages 172-177

  Geller, J Christoph ^a   Geller, Marika ^a   Carlson, Mark D ^b   Waldo, Albert L ^a,b  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LIVER ENZYME; MORACIZINE;

ADULT; AGED; ARTICLE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERANCE; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HEART VENTRICLE EXTRASYSTOLE; HEART VENTRICLE TACHYCARDIA; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RASH; SINUS RHYTHM;

ADULT; AGED; AGED, 80 AND OVER; ANTI-ARRHYTHMIA AGENTS; ATRIAL FIBRILLATION; ELECTROCARDIOGRAPHY; FEMALE; HEART RATE; HUMANS; MALE; MIDDLE AGED; MORICIZINE; RECURRENCE; RETROSPECTIVE STUDIES;

EID: 0035863602     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(00)01311-4     Document Type: Article

References (30)

1. Classification of the antiarrhythmic action of moricizine
2. Ethmozine: A new antiarrhythmic agent developed in the USSR: Efficacy and tolerance
3. Moricizine
4. Ethmozine, a new antiarrhythmic drug for suppressing ventricular premature complexes
5. Ethmozine suppression of single and repetitive ventricular premature depolarization during therapy: Documentation of efficacy and long-term safety
6. Comparative effect of disopyramide and ethmozine in suppressing complex ventricular arrhythmias by use of a double-blind, placebo-controlled, longitudinal crossover design
7. Effect of moricizine hydrochloride in reducing chronic high-frequency ventricular arrhythmia: Results of a prospective, controlled trial
8. Efficacy and safety of moricizine in patients with ventricular tachycardia: Results of a placebo-controlled prospective long-term clinical trial
9. Ethmozine for premature ventricular complexes
10. Antiarrhythmic efficacy of ethmozine in patients with ventricular tachycardia as determined by programmed electrical stimulation
11. Ethmozine therapy for complex ventricular arrhythmias
12. Ethmozine, effects of intravenous administration of paroxysmal supraventricular tachycardia in the ventricular pre-excitation syndrome
13. Ethmozine effects of intravenous drug administration on atrioventricular nodal reentrant tachycardia
14. Ethmozine (moricizine HCl). a promising drug for "automatic" atrial ectopic tachycardia
15. Efficacy and safety of moricizine in patients with congestive heart failure: A summary of the experience in the United States
16. Moricizine. A review of its pharmacological properties, and therapeutic efficacy in cardiac arrhythmias
17. Comparisons of efficacy and tolerance of moricizine with other antiarrhythmic agents in the treatment of chronic ventricular arrhythmias
18. Mechanism of interruption of atrial flutter by moricizine. Electrophysiological and multiplexing studies in the canine sterile pericarditis model of atrial flutter
19. Preliminary report: Effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction
20. Effect of the antiarrhythmic agent moricizine on survival after myocardial infarction
21. Non-parametric estimation from incomplete observations
22. Serial antiarrhythmic drug treatment to maintain sinus rhythm after electrical cardioversion for chronic atrial fibrillation or atrial flutter
23. Drugs after cardioversion to prevent relapses of chronic AF or flutter
24. Efficacy and safety of quinidine therapy for maintenance of sinus rhythm after cardioversion. A meta-analysis of randomized control-trials
25. Dofetilide in the treatment of atrial fibrillation in patients with impaired left ventricular function: Atrial fibrillation in the DIAMOND study (abstr)
26. Conversion of atrial fibrillation and maintenance of sinus rhythm by dofetilide. The EMERALD (European and Australian Multicenter Evaluative Research on Atrial Fibrillation Dofetilide) Study (abstr)
27. Azimilide treatment of atrial fibrillation (abstr)
28. Measures of drug efficacy in treating atrial fibrillation
29. Proarrhythmia in patients treated for atrial fibrillation or flutter
30. Hybrid pharmacologic and ablative therapy: A novel and effective approach for the management of atrial fibrillation